Key facts
- Glacies Biome’s last known valuation is $2.6M (Apr 2025).
- It has raised $160K.
- Notable investors include Berkeley SkyDeck, Fit 4 Start, Caucasus Ventures, Cariplo Factory, SVBIG.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Glacies Biome
- ·The full record, as it builds
Funding rounds
No funding rounds for Glacies Biome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Glacies Biome
Developer of a clinical data analysis platform designed to help healthcare providers interpret patient and microbiome data for personalized treatment decisions. The company offers a secure dashboard that integrates laboratory results with patient health history and applies data processing and artificial intelligence for clinical insights, enabling clinics and healthcare practitioners to support personalized, data-driven care.
- Sector
- Healthcare
- HQ
- Esch-sur-Alzette, Luxembourg
- Founded
- 2024
- Employees
- 12
- Website
- glacies.bio/
- Ownership
- Privately Held (backing)
Glacies Biome doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Glacies Biome shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Glacies Biome in its N-PORT filings yet. We sweep new filings monthly.